Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.27 billion. The enterprise value is $1.42 billion.
| Market Cap | 1.27B |
| Enterprise Value | 1.42B |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 89.30 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 89.30M |
| Shares Outstanding | 89.30M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 113.87% |
| Float | 80.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.45 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.69
| Current Ratio | 4.69 |
| Quick Ratio | 4.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.79 |
Financial Efficiency
Return on equity (ROE) is -426.43% and return on invested capital (ROIC) is -21.61%.
| Return on Equity (ROE) | -426.43% |
| Return on Assets (ROA) | -17.94% |
| Return on Invested Capital (ROIC) | -21.61% |
| Return on Capital Employed (ROCE) | -31.25% |
| Weighted Average Cost of Capital (WACC) | 6.60% |
| Revenue Per Employee | $972,074 |
| Profits Per Employee | -$702,963 |
| Employee Count | 298 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 8.41 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.09% in the last 52 weeks. The beta is 0.45, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +4.09% |
| 50-Day Moving Average | 16.95 |
| 200-Day Moving Average | 20.17 |
| Relative Strength Index (RSI) | 44.21 |
| Average Volume (20 Days) | 2,952,670 |
Short Selling Information
The latest short interest is 18.00 million, so 20.16% of the outstanding shares have been sold short.
| Short Interest | 18.00M |
| Short Previous Month | 18.23M |
| Short % of Shares Out | 20.16% |
| Short % of Float | 22.37% |
| Short Ratio (days to cover) | 8.03 |
Income Statement
In the last 12 months, SNDX had revenue of $289.68 million and -$209.48 million in losses. Loss per share was -$2.37.
| Revenue | 289.68M |
| Gross Profit | 8.35M |
| Operating Income | -178.64M |
| Pretax Income | -209.48M |
| Net Income | -209.48M |
| EBITDA | -178.62M |
| EBIT | -178.64M |
| Loss Per Share | -$2.37 |
Balance Sheet
The company has $437.26 million in cash and $589.42 million in debt, with a net cash position of -$152.16 million or -$1.70 per share.
| Cash & Cash Equivalents | 437.26M |
| Total Debt | 589.42M |
| Net Cash | -152.16M |
| Net Cash Per Share | -$1.70 |
| Equity (Book Value) | -17.18M |
| Book Value Per Share | -0.19 |
| Working Capital | 446.47M |
Cash Flow
In the last 12 months, operating cash flow was -$177.36 million and capital expenditures -$96,000, giving a free cash flow of -$177.46 million.
| Operating Cash Flow | -177.36M |
| Capital Expenditures | -96,000 |
| Depreciation & Amortization | 18,000 |
| Net Borrowing | 243.84M |
| Free Cash Flow | -177.46M |
| FCF Per Share | -$1.99 |
Margins
Gross margin is 2.88%, with operating and profit margins of -61.67% and -72.32%.
| Gross Margin | 2.88% |
| Operating Margin | -61.67% |
| Pretax Margin | -72.32% |
| Profit Margin | -72.32% |
| EBITDA Margin | -61.66% |
| EBIT Margin | -61.67% |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | -16.61% |
| FCF Yield | -13.78% |
Analyst Forecast
The average price target for SNDX is $37.27, which is 161.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.27 |
| Price Target Difference | 161.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 54.00% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |